TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies-Reference-Cited by-同舟云学术

TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies

Published:2018-02-22 Issue:4 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Ahmed Mahiuddin,Lopez-Albaitero Andres,Pankov Dmitry,Santich Brian H.,Liu Hong,Yan Su,Xiang Jingyi,Wang Pei,Hasan Aisha N.,Selvakumar Annamalai,O’Reilly Richard J.,Liu Cheng,Cheung Nai-Kong V.^ORCID

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/97805/files/pdf

Reference69 articles.

1. Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review;de-The;IARC Sci Publ,1975

2. Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus

3. EBV Persistence--Introducing the Virus;Thorley-Lawson;Curr Top Microbiol Immunol,2015

4. Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010

5. EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models;Emerging Microbes & Infections;2024-08-08

2. The Future of TCR-like Antibodies in Diagnosis and Potential Application Targets;Current Molecular Medicine;2024-05-27

3. Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression;PLOS Pathogens;2024-04-29

4. CD39 expression by regulatory T cells participates in CD8+ T cell suppression during experimental Trypanosoma cruzi infection;PLOS Pathogens;2024-04-29

5. Combinations of radiotherapy with immunotherapy in nasopharyngeal carcinoma;International Immunopharmacology;2023-12